David Eifrig
David Eifrig is a Senior Partner and Editor at Stansberry Research, an independent financial research firm. Dr. Eifrig is the Editor of Retirement Millionaire, a monthly advisory that shows readers how to live a millionaire lifestyle on less money than you'd imagine possible. In addition, he serves as the Editor of Retirement Trader, Income Intelligence, and Prosperity Investor. Prior to joining Stansberry in 2008, Dr. Eifrig worked in arbitrage and trading groups with major Wall Street investment banks, including Goldman Sachs, Chase Manhattan, and Yamaichi in Japan. In 1995, he retired from the "Street," went to UNC-Chapel Hill for medical school, and became an ophthalmologist. He is also the author of five books with 4+-star ratings on Amazon.
David Eifrig Professional Experience / Academic History
Professional Experience
-
Editor, Analyst, and Physician
-
Vice President
Academic History
-
MD, Medicine
-
MBA, Finance and International Policy
EARLY CAREER
Dr. Eifrig also completed a research fellowship in molecular genetics at Duke University and became a board-eligible eye surgeon.
He has been cited in numerous scientific journals and helped establish a biotech company, Mirus, which was sold to Roche for $125 million in 2008.